BOLANLE AKINRONBI: Open Payments
NPI 1912290602 · CRANFORD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$179 in 10 payments from 5 companies in 2025. Trend: 2023 $200 · 2024 $305 · 2025 $179
Food & beverage: $179
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $104 |
| Alkermes, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: VRAYLAR, REXULTI, ARISTADA, COBENFY.
Industry payments across NJ — which companies pay providers there.
